Processa pharmaceuticals schedules conference call to discuss fourth quarter results and provide drug development update on march 25 at 5:30 p.m. et

Hanover, md., march 22, 2021 (globe newswire) -- processa pharmaceuticals, inc. (nasdaq: pcsa), (“processa” or the “company”), a clinical-stage biopharmaceutical company developing products to improve the survival and/or quality of life for patients who have unmet medical needs, today announces it will host a conference call and live webcast on march 25, 2021, at 5:30 p.m. eastern time to discuss its fourth quarter 2020 results and provide an update on the company's clinical pipeline.
PCSA Ratings Summary
PCSA Quant Ranking